TG Therapeutics, Inc. (TGTX)
NASDAQ: TGTX · Real-Time Price · USD
25.71
+1.36 (5.59%)
At close: Oct 29, 2024, 4:00 PM
25.50
-0.21 (-0.82%)
After-hours: Oct 29, 2024, 7:25 PM EDT
TG Therapeutics Stock Forecast
Stock Price Forecast
The 6 analysts with 12-month price forecasts for TG Therapeutics stock have an average target of 36.33, with a low estimate of 20 and a high estimate of 50. The average target predicts an increase of 41.31% from the current stock price of 25.71.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for TGTX stock from 7 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | May '24 | Jun '24 | Jul '24 | Aug '24 | Sep '24 | Oct '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 4 | 4 | 4 | 4 | 4 | 5 |
| Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Hold | 1 | 1 | 1 | 1 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 6 | 6 | 6 | 6 | 6 | 7 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| TD Cowen | TD Cowen | Strong Buy Initiates $50 | Strong Buy | Initiates | $50 | +94.48% | Oct 29, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $49 | Strong Buy | Reiterates | $49 | +90.59% | Sep 18, 2024 |
| B. Riley Securities | B. Riley Securities | Strong Buy Maintains $29 → $34 | Strong Buy | Maintains | $29 → $34 | +32.24% | Aug 7, 2024 |
| Goldman Sachs | Goldman Sachs | Hold Maintains $18 → $20 | Hold | Maintains | $18 → $20 | -22.21% | Aug 7, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $49 | Strong Buy | Reiterates | $49 | +90.59% | Aug 6, 2024 |
Financial Forecast
Revenue This Year
334.94M
from 233.66M
Increased by 43.34%
Revenue Next Year
505.05M
from 334.94M
Increased by 50.79%
EPS This Year
0.15
from 0.09
Increased by 68.54%
EPS Next Year
0.77
from 0.15
Increased by 411.86%
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 432.3M | 603.7M | 1.1B | ||
| Avg | 334.9M | 505.1M | 719.2M | ||
| Low | 301.1M | 366.3M | 444.6M |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 85.0% | 80.2% | 114.2% | ||
| Avg | 43.3% | 50.8% | 42.4% | ||
| Low | 28.9% | 9.4% | -12.0% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 0.61 | 1.11 | 3.31 | ||
| Avg | 0.15 | 0.77 | 1.57 | ||
| Low | -0.04 | 0.32 | 0.43 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 582.2% | 639.8% | 329.5% | ||
| Avg | 68.5% | 411.9% | 103.8% | ||
| Low | - | 115.0% | -44.0% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.